Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MG-K10 in adult atopic dermatitis
NCT05466877Phase 2Unknown
- Sponsor
- Hunan Mabgeek Biotechnology
- Start
- Aug 2022
- Primary completion
- Sep 2023
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of comekibart in atopic dermatitis (AD), sponsored by Hunan Mabgeek Biotechnology. Status: unknown.
02
Drugs
comekibart
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT05466877.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05466877.